IL6 and lung adenocarcinoma: Beyond its direct regulation of cell proliferation and apoptosis, IRF8 inhibits the activation of the IL6-JAK-STAT3 pathway in lung adenocarcinoma cells, reducing the differentiation of MDSCs and significantly weakening the immunosuppressive microenvironment, thereby indirectly suppressing the progression of lung adenocarcinoma (61).